Mrv1909 11212219322D 17 18 0 0 1 0 999 V2000 0.7145 6.7661 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 5.9411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 5.5286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4289 4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 4.2911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 4.2911 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 4.7036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.0000 5.5286 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 3.4661 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.3819 2.9812 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1.1270 2.1965 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 1.6119 1.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4324 1.6153 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.3020 2.1965 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.1830 1.5291 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 0.0470 2.9812 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -0.7376 3.2361 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 0 2 3 2 0 0 0 0 3 4 1 0 0 0 0 4 5 2 0 0 0 0 4 6 1 0 0 0 0 6 7 1 0 0 0 0 7 8 1 0 0 0 0 2 8 1 0 0 0 0 9 6 1 6 0 0 0 9 10 1 0 0 0 0 11 10 1 0 0 0 0 11 12 1 6 0 0 0 12 13 1 0 0 0 0 14 11 1 0 0 0 0 14 15 1 1 0 0 0 14 16 1 0 0 0 0 16 9 1 0 0 0 0 16 17 1 1 0 0 0 M END > DB17151 > drugbank > NC1=NC(=O)N(CN1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O > InChI=1S/C8H14N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h3-6,13-15H,1-2H2,(H3,9,10,11,16)/t3-,4-,5-,6-/m1/s1 > LJIRBXZDQGQUOO-KVTDHHQDSA-N > C8H14N4O5 > 246.223 > 246.096419567 > 8 > 31 > 1.001329481656059 > 22.909831154323065 > 1 > 5 > 0 > 0 > 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,5,6-tetrahydro-1,3,5-triazin-2-one > -2.76 > -3.1539692436666664 > -0.70 > 0 > 1 > 2 > 0 > 13.935543424464203 > 12.559216820650557 > 6.756048942032949 > 140.64000000000001 > 52.59459999999999 > 2 > 1 > 4.92e+01 g/l > 5,6-dihydro-5-azacytidine > 0 > DB17151 > investigational > 5,6-dihydro-5-azacytidine > 1,3,5-triazin-2(1h)-one, 4-amino-5,6-dihydro-1-.beta.-d-ribofuranosyl- $$$$